Claritev Corporation expanded its Board of Directors from eleven to twelve members and appointed Jennifer Main as a Class II director effective October 15, 2026. Main joins the Audit Committee, replacing Jason Kap, who ceased serving on that committee. The company stated the appointment adds deep public sector healthcare and financial leadership expertise to support Claritev's growth strategy. Main currently serves as CFO of RealMDai (dba Certuma) and Overture Life and previously held senior roles at CMS and the U.S. Department of Treasury. Claritev is a healthcare technology, data, and insights company focused on delivering affordability, transparency, and quality across the U.S. healthcare system.
